D-0107-2027 Class II Ongoing

Recalled by Direct Rx — Dawsonville, GA

FDA drug recall D-0107-2027 was initiated by Direct Rx on Sep 29, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 493 jars.

Recall details

Product Type
Drugs
Report Date
Nov 4, 2026
Initiation Date
Sep 29, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
493 jars

Product description

Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the United States

Code information

LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0107-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0107-2027. Report a data issue: hello@regdatalab.com.